Share-based Payment Arrangement, Expense of DMK PHARMACEUTICALS Corp from 31 Mar 2012 to 30 Sep 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
DMK PHARMACEUTICALS Corp quarterly and annual Share-based Payment Arrangement, Expense in USD history and change rate from 31 Mar 2012 to 30 Sep 2023.
  • DMK PHARMACEUTICALS Corp Share-based Payment Arrangement, Expense for the quarter ending 30 Sep 2023 was $44,693, a 160% decline year-over-year.
  • DMK PHARMACEUTICALS Corp Share-based Payment Arrangement, Expense for the twelve months ending 30 Sep 2023 was $249,160.
  • DMK PHARMACEUTICALS Corp annual Share-based Payment Arrangement, Expense for 2022 was $340,270, a 117% decline from 2021.
  • DMK PHARMACEUTICALS Corp annual Share-based Payment Arrangement, Expense for 2021 was $2,016,640.
  • DMK PHARMACEUTICALS Corp annual Share-based Payment Arrangement, Expense for 2012 was $36,792, a 90% decline from 2011.
Source SEC data
View on sec.gov
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Quarterly (USD)
Share-based Payment Arrangement, Expense, YoY Quarterly Change (%)
Share-based Payment Arrangement, Expense, Annual (USD)
Share-based Payment Arrangement, Expense, YoY Annual Change (%)

DMK PHARMACEUTICALS Corp Quarterly Share-based Payment Arrangement, Expense (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q3 2023 $249,160 $44,693 -$119,181 -160% 01 Jul 2023 30 Sep 2023 10-Q 14 Nov 2023 2023 Q3
Q2 2023 $129,979 $52,198 +$513,115 01 Apr 2023 30 Jun 2023 10-Q 21 Aug 2023 2023 Q2
Q1 2023 $643,094 $69,294 -$302,824 -81% 01 Jan 2023 31 Mar 2023 10-Q 15 May 2023 2023 Q1
Q4 2022 $340,270 $325,959 01 Oct 2022 31 Dec 2022 10-K 16 Mar 2023 2022 FY
Q3 2022 $74,488 01 Jul 2022 30 Sep 2022 10-Q 14 Nov 2023 2023 Q3
Q2 2022 $460,917 01 Apr 2022 30 Jun 2022 10-Q 21 Aug 2023 2023 Q2
Q1 2022 $372,118 01 Jan 2022 31 Mar 2022 10-Q 15 May 2023 2023 Q1
Q2 2013 $17,750 01 Apr 2013 30 Jun 2013 10-Q 19 Aug 2013 2013 Q1

DMK PHARMACEUTICALS Corp Annual Share-based Payment Arrangement, Expense (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2022 $340,270 -$2,356,910 -117% 01 Jan 2022 31 Dec 2022 10-K 16 Mar 2023 2022 FY
2021 $2,016,640 01 Jan 2021 31 Dec 2021 10-K 16 Mar 2023 2022 FY
2012 $36,792 -$328,092 -90% 01 Apr 2012 31 Mar 2013 10-K 03 Jul 2013 2012 FY
2011 $364,884 01 Apr 2011 31 Mar 2012 10-K 03 Jul 2013 2012 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.